Not Rated
Fund Size
(0.06% of Investment in Category)
|
Expense Ratio
(0.91% Category average)
|
Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
---|---|---|---|---|---|---|
1 Week | 07-Oct-25 | 10075.10 | 0.75% | - | -0.16% | 24/225 |
1 Month | 12-Sep-25 | 9875.70 | -1.24% | - | -0.09% | 175/226 |
3 Month | 14-Jul-25 | 9982.90 | -0.17% | - | 0.87% | 124/216 |
6 Month | 11-Apr-25 | 11070.40 | 10.70% | - | 14.38% | 160/212 |
YTD | 01-Jan-25 | 9829.70 | -1.70% | - | 3.32% | 152/201 |
Since Inception | 27-Dec-24 | 9929.00 | -0.71% | -0.89% | 13.76% | 184/198 |
Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
---|---|---|---|---|---|
No Data Found |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
---|---|---|---|---|---|---|---|---|
# Divis Laboratories Ltd. | Pharmaceuticals | 250 | 7.75% | 0.00% | 9.27% (Apr 2025) | 0% (Sep 2024) | 43.94 k | 1.52 k |
# Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 242.7 | 7.53% | 0.00% | 8.83% (Apr 2025) | 0% (Sep 2024) | 1.52 L | 2.60 k |
# Apollo Hospitals Enterprises Ltd. | Hospital | 202.7 | 6.29% | 0.00% | 6.29% (Aug 2025) | 0% (Sep 2024) | 27.36 k | 0.00 |
# Cipla Ltd. | Pharmaceuticals | 175.6 | 5.45% | 0.00% | 8.33% (Apr 2025) | 0% (Sep 2024) | 1.17 L | 0.00 |
# Fortis Healthcare Ltd. | Hospital | 123.6 | 3.83% | 0.00% | 3.51% (Aug 2025) | 0% (Sep 2024) | 1.27 L | 0.00 |
# Neuland Laboratories Ltd. | Pharmaceuticals | 121.8 | 3.78% | 0.00% | 3.29% (Jan 2025) | 0% (Sep 2024) | 8.34 k | 350.00 |
# Biocon Ltd. | Pharmaceuticals | 115.8 | 3.59% | 0.00% | 4.24% (Jan 2025) | 0% (Sep 2024) | 3.40 L | 12.00 k |
Aurobindo Pharma Ltd. : Futures Near | Pharmaceuticals | 110.8 | 3.44% | 0.00% | 0% (Oct 2025) | 0% (Oct 2025) | 1.02 L | 1.02 L |
# Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 110.7 | 3.43% | 0.00% | 8.46% (Jan 2025) | 0% (Sep 2024) | 90.44 k | 0.00 |
# Emcure Pharmaceuticals Ltd. | Pharmaceuticals | 105 | 3.26% | 0.00% | 3.45% (Aug 2025) | 0% (Sep 2024) | 82.00 k | 0.00 |
Name | Type of Instrument | Weight (%) |
---|---|---|
TREPS | TREPS | 2.97% |
Net Receivables | Net Receivables | -1.72% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
Out of 19 mutual fund schemes offered by this AMC, 2 is/are ranked 4 * , 1 is/are ranked 2 * , and 16 schemes are not ranked. See more about AMC
Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
---|---|---|---|---|---|---|---|
Bajaj Finserv Flexi Cap Fund - Direct Plan - Growth | NA | 5632.23 | 0.24 | 1.20 | 17.07 | 2.72 | 0.00 |
Bajaj Finserv Liquid Fund - Direct Plan - Growth | 4 | 5196.19 | 0.49 | 1.43 | 3.05 | 6.83 | 0.00 |
Bajaj Finserv Money Market Fund - Direct Plan - Growth | 4 | 5177.96 | 0.58 | 1.52 | 3.57 | 7.87 | 0.00 |
Bajaj Finserv Large and Mid Cap Fund - Direct Plan - Growth | NA | 2125.78 | -0.32 | -1.49 | 11.34 | -0.52 | 0.00 |
Bajaj Finserv Large Cap Fund - Direct Plan - Growth | NA | 1603.94 | 0.87 | 0.55 | 11.60 | -0.11 | 0.00 |
Bajaj Finserv Small Cap Fund - Direct Plan - Growth | NA | 1378.47 | -1.03 | 0.00 | 0.00 | 0.00 | 0.00 |
Bajaj Finserv Arbitrage Fund - Direct Plan - Growth | 2 | 1295.52 | 0.49 | 1.40 | 3.06 | 6.78 | 0.00 |
Bajaj Finserv Balanced Advantage - Direct Plan - Growth | NA | 1285.76 | 1.01 | 0.14 | 9.27 | 2.24 | 0.00 |
Bajaj Finserv Multi Asset Allocation Fund - Direct Plan - Growth | NA | 1216.11 | 4.87 | 5.82 | 13.94 | 10.01 | 0.00 |
Bajaj Finserv Multi Cap Fund - Direct Plan - Growth | NA | 934.87 | -0.54 | -2.88 | 9.48 | 0.00 | 0.00 |